Cargando…
Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates
Complete response (CR) rates reported for cytotoxic chemotherapy for late-stage cancer patients are generally low, with few exceptions, regardless of the solid cancer type or drug regimen. We investigated CR rates reported in the literature for clinical trials using chemotherapy alone, across a wide...
Autores principales: | Ashdown, Martin L., Robinson, Andrew P., Yatomi-Clarke, Steven L., Ashdown, M. Luisa, Allison, Andrew, Abbott, Derek, Markovic, Svetomir N., Coventry, Brendon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4706056/ https://www.ncbi.nlm.nih.gov/pubmed/26834979 http://dx.doi.org/10.12688/f1000research.6760.1 |
Ejemplares similares
-
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?
por: Coventry, Brendon J, et al.
Publicado: (2009) -
Mathematical modeling of immune kinetics in advanced cancer through meta-analyses of complete response rates: immune synchronisation emerges as the likely key determinant of clinical response
por: Ashdown, Martin L, et al.
Publicado: (2013) -
Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation
por: Coventry, Brendon J, et al.
Publicado: (2012) -
The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses
por: Coventry, Brendon J, et al.
Publicado: (2012) -
Clinical outcomes of Interleukin-2 therapy in advanced cancer: meta-analysis of over 62 trials
por: Coventry, Brendon J, et al.
Publicado: (2013)